Compounds > dephostatin
Page last updated: 2024-10-25

dephostatin and Diabetes Mellitus, Type 2

dephostatin has been researched along with Diabetes Mellitus, Type 2 in 2 studies

dephostatin: from Streptomyces sp. MJ742-NF5; structure given in first source

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hiroki, A1
Hatakeyama, H1
Kawakami, M1
Watanabe, T1
Takei, I1
Umezawa, K2
Suzuki, T1

Reviews

1 review available for dephostatin and Diabetes Mellitus, Type 2

ArticleYear
[Protein-tyrosine phosphatase inhibitors].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 2000, Volume: 45, Issue:6 Suppl

    Topics: Animals; Diabetes Mellitus, Type 2; Drug Design; Enzyme Inhibitors; Humans; Hydroquinones; Protein T

2000

Other Studies

1 other study available for dephostatin and Diabetes Mellitus, Type 2

ArticleYear
Antidiabetic effect of a nitrosamine-free dephostatin analogue, methoxime-3,4-dephostatin, in db/db mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2002, Volume: 56, Issue:4

    Topics: 3T3 Cells; Animals; Catecholamines; Cells, Cultured; Diabetes Mellitus, Type 2; Glucose; Hydroquinon

2002